Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
Congress Resources
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to Develop Guidelines
Funding for Guideline Updates
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Session
IBD (Posters)
DEEP REMISSION IN CROHN'S DISEASE ON BIOLOGIC THERAPY: TOWARDS A NEW DEFINITION
CAN THE LEMANN INDEX AT DIAGNOSIS PREDICT THE RISK OF EARLY SURGERY IN CROHN'S DISEASE?
ASSESSMENT OF THE DEGREE OF INTESTINAL DESTRUCTION IN CROHN'S DISEASE AT THE TIME OF DIAGNOSIS
BIOLOGICS AND SMALL MOLECULES COMBOTHERAPIES: PROMISING EXPERIENCE IN REFRACTORY IBD PATIENTS
BOTH SINGLE AND MULTIPLE SWITCHING BETWEEN INFLIXIMAB BIOSIMILARS CAN BE SAFE AND EFFECTIVE IN IBD: REAL WORLD OUTCOMES FROM THE EDINBURGH IBD UNIT
SAFETY OF REDUCED CLINICAL MONITORING IN PATIENTS WITH STABLE INFLAMMATORY BOWEL DISEASE ON MAINTENANCE THIOPURINE THERAPY
COVID-19 PANDEMIC PSYCHOLOGICAL EFFECTS ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN TUNISIA
CHARACTERIZATION OF CYTOKINE AND DRUG CONCENTRATIONS IN SERUM, MUCOSA AND FAECES DURING INDUCTION TREATMENT OF SEVERE ULCERATIVE COLITIS WITH INFLIXIMAB
TOFACITINIB IN ULCERATIVE COLITIS: SHORT TERM OUTCOMES IN REAL WORLD EXPERIENCE IN THE SOUTH OF SPAIN
IDENTIFYING PATIENTS WITH INFLAMMATORY BOWEL DISEASES UNDER SUBCUTANEOUS BIOTHERAPY USING A MEDICATION DISPENSE DATABASE: FEASIBILITY, AND IMPACT OF COVID-19
INVOLVEMENT OF MACROPHAGES IN THE ACTIVATION OF MESENCHYMAL EPITHELIAL TRANSITION IN CROHN'S DISEASE: ROLE OF THE MICROENVIRONMENT
BASELINE HYPERTROPHY OF THE SUBMUCOSA AT INTESTINAL ULTRASOUND PREDICTS FAILURE OF TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS
COLONIC MUCOSA BARRIER DEFECTS IN COLLAGENOUS AND ISCHEMIC COLITIS
PROPENSITY SCORE ADJUSTED REAL WORLD EFFECTIVENESS OF VEDOLIZUMAB VS. ANTI-TNF IN BIOLOGIC-NAÏVE CROHN'S DISEASE PATIENTS: INDUCTION PHASE RESULTS FROM THE PROSPECTIVE, OBSERVATIONAL VEDOIBD STUDY IN GERMANY
INFLIXIMAB PHARMACOKINETIC PEAK CO AND 1-WEEK SERUM LEVELS PREDICT 8-WEEK TROUGH LEVELS IN INFLAMMATORY BOWEL DISEASE
REAL-LIFE EFFECTIVENESS AND SAFETY OF USTEKINUMAB INDUCTION THERAPY FOR KOREAN PATIENTS WITH CROHN'S DISEASE: A KASID PROSPECTIVE MULTICENTER STUDY
PATIENTS WITH INFLAMMATORY BOWEL DISEASE SHOULD BE VACCINATED AGAINST PNEUMOCOCCUS AND INFLUENZA DESPITE IMMUNOSUPPRESSIVE THERAPY
BIOMARKERS AND BOWEL URGENCY IN RESPONSE TO MIRIKIZUMAB FOR ULCERATIVE COLITIS
IN CONTRAST TO ORAL IRON THERAPY, INTRAVENOUS IRON THERAPY IS NEITHER INFLUENCED BY, NOR DOES IT EXACERBATE, SYSTEMIC INFLAMMATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
UPADACITINIB TREATMENT IMPROVES HEALTH-RELATED QUALITY OF LIFE AMONG PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 INDUCTION STUDIES U-ACHIEVE AND U-ACCOMPLISH
Item 21 - 40 / 568
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
Chat with us
, powered by
LiveChat